Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
Zealthy vs Hims & Hers
Zealthy and Hims & Hers both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
Zealthy
Ranked #298 · Grade C
Best for: Nothing, while the federal case is open. It stays on the board for transparency, not as a suggestion.
Visit ZealthyHims & Hers
Higher scoreRanked #43 · Grade C
Best for: A mother who specifically wants FDA-approved brand medication with the manufacturer's own labeling, and who has done the arithmetic on a $149 monthly membership sitting on top of the drug price.
Visit Hims & HersThe verdict
Hims & Hers edges out Zealthy on the Rx-Readiness Score, 69 to 39 (C vs C). A mother who specifically wants FDA-approved brand medication with the manufacturer's own labeling, and who has done the arithmetic on a $149 monthly membership sitting on top of the drug price.
Zealthy is still a genuine option — fDA warning letter #716501 (September 2025), which names getzealthy.com, and in April 2026 the FTC and DOJ moved to seize the company and freeze its assets. Read both before anything else here. On the money: read live on 26 August 2026, self-pay semaglutide is advertised at "as little as $151/month" and brand Ozempic, Wegovy, Zepbound and Mounjaro at "as low as $25/month" with insurance — two figures that are not comparable, because the second is a copay that depends on your plan and the same paragraph quotes $1,349 without coverage. No tirzepatide price is published anywhere. A "$96 off your first month" banner runs site-wide and its own policy confirms the rate reverts to full afterward. Cancellation is self-serve and documented step by step, but there is no prorated refund, medication is final once shipped, and the policy warns members may be required to sign up for multiple months to keep supply continuous. Four months after the federal petition it is still trading normally under the same entity, FitRX, LLC dba Zealthy, at the same New York address the FDA letter used. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Zealthy | Hims & Hers |
|---|---|---|
| Rx-Readiness Score | 39/100 · C | 69/100 · C |
| Overall rank | #298 | #43 |
| Semaglutide | From $151/mo self-pay | $149/mo for the Wegovy Pill, medication only |
| Tirzepatide | Not priced on the public site | $299/mo for the Zepbound vial, medication only |
| Coverage | Not published on the public site | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Zealthy
Ranked #298 · Grade C
What we like
- Both self-pay and insured figures are published on the public page before any form
- Brand Ozempic, Wegovy, Zepbound and Mounjaro sit on the menu alongside compounded semaglutide, and it works with major insurers
- Same-day appointments are advertised, and the published intake takes about five minutes before the visit
The caveats
- April 2026: the FTC and DOJ asked a federal court to place Zealthy in receivership and freeze its assets, alleging deceptive disclosures, obstructive cancellation and review manipulation
- The same complaint alleges misuse of clinicians' NPI numbers to issue prescriptions without their knowledge or consent — the government's words are that Zealthy is "actively deceiving telehealth patients, endangering their safety, and raiding their bank accounts". These are allegations, not findings; the case is ongoing
- Separately, and earlier: FDA warning letter #716501, dated September 9, 2025, to FitRX, LLC dba Zealthy, over the unlawful sale of unapproved and misbranded compounded semaglutide — the letter names getzealthy.com, and its address, 30 Irving Pl in New York, is the one the live site prints today
Hims & Hers
Ranked #43 · Grade C
What we like
- Entirely FDA-approved brand product now — Wegovy, Zepbound, Ozempic, Mounjaro and the new Foundayo tablet, not compounded
- Two oral routes that are FDA-approved rather than compounded: the Wegovy Pill and the new Ozempic Pill, both posted at from $149 a month
- Every price is visible on one open page before you enter anything, each tagged "Membership required" so the structure is not hidden
The caveats
- Every posted price is medication only: a required $149/month membership is billed separately, which roughly doubles the real cost
- The $39 first month auto-renews at $149, so the number you sign up at is not the number you keep paying
- Mounjaro and one of two Zepbound listings are posted at $1,899 a month on the same page as Zepbound vials at $299, with no explanation of the difference
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Zealthy and Hims & Hers against other providers on our shortlist.
- Zealthy vs CoreAge Rx
- Zealthy vs Gala Health
- Zealthy vs Direct Meds
- Hims & Hers vs CoreAge Rx
- Hims & Hers vs Trimi Health
- Hims & Hers vs Strut Health
Or browse the full comparison hub.